161 related articles for article (PubMed ID: 29080080)
1. Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.
Fang Y; Shen X
Cancer Metastasis Rev; 2017 Dec; 36(4):669-682. PubMed ID: 29080080
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration.
Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
[TBL] [Abstract][Full Text] [Related]
3. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
Fang Y; Fu D; Shen XZ
Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
[TBL] [Abstract][Full Text] [Related]
4. Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains.
Zhou ZR; Zhang YH; Liu S; Song AX; Hu HY
Biochem J; 2012 Jan; 441(1):143-9. PubMed ID: 21851340
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin recognition of BAP1: understanding its enzymatic function.
Hanpude P; Bhattacharya S; Kumar Singh A; Kanti Maiti T
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28935764
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain.
Nishio K; Kim SW; Kawai K; Mizushima T; Yamane T; Hamazaki J; Murata S; Tanaka K; Morimoto Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):855-60. PubMed ID: 19836345
[TBL] [Abstract][Full Text] [Related]
7. Power and promise of ubiquitin carboxyl-terminal hydrolase 37 as a target of cancer therapy.
Chen YJ; Ma YS; Fang Y; Wang Y; Fu D; Shen XZ
Asian Pac J Cancer Prev; 2013; 14(4):2173-9. PubMed ID: 23725108
[TBL] [Abstract][Full Text] [Related]
8. Essential role of ubiquitin C-terminal hydrolases UCHL1 and UCHL3 in mammalian oocyte maturation.
Mtango NR; Sutovsky M; Vandevoort CA; Latham KE; Sutovsky P
J Cell Physiol; 2012 May; 227(5):2022-9. PubMed ID: 21751213
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
10. Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases.
Hewitt CS; Krabill AD; Das C; Flaherty DP
Biochemistry; 2020 Sep; 59(37):3447-3462. PubMed ID: 32865982
[TBL] [Abstract][Full Text] [Related]
11. Friend or Foe: UCHL3 Mediated Carcinogenesis and Current Approaches in Small Molecule Inhibitors' Development.
Samy MA; Abd El Fatah NM; Yahia SE; Arafa RK
Curr Med Chem; 2021; 28(42):8782-8799. PubMed ID: 34238144
[TBL] [Abstract][Full Text] [Related]
12. A fluorescence assay for elucidating the substrate specificities of deubiquitinating enzymes.
Yin ST; Huang H; Zhang YH; Zhou ZR; Song AX; Hong FS; Hu HY
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):76-9. PubMed ID: 22086173
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin C-terminal hydrolase-activity is involved in sperm acrosomal function and anti-polyspermy defense during porcine fertilization.
Yi YJ; Manandhar G; Sutovsky M; Li R; Jonáková V; Oko R; Park CS; Prather RS; Sutovsky P
Biol Reprod; 2007 Nov; 77(5):780-93. PubMed ID: 17671268
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes.
Dang LC; Melandri FD; Stein RL
Biochemistry; 1998 Feb; 37(7):1868-79. PubMed ID: 9485312
[TBL] [Abstract][Full Text] [Related]
15. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.
Meray RK; Lansbury PT
J Biol Chem; 2007 Apr; 282(14):10567-75. PubMed ID: 17259170
[TBL] [Abstract][Full Text] [Related]
16. The interaction between ubiquitin C-terminal hydrolase 37 and glucose-regulated protein 78 in hepatocellular carcinoma.
Fang Y; Mu J; Ma Y; Ma D; Fu D; Shen X
Mol Cell Biochem; 2012 Jan; 359(1-2):59-66. PubMed ID: 21800051
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.
Bheda A; Shackelford J; Pagano JS
PLoS One; 2009 Aug; 4(8):e6764. PubMed ID: 19707515
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin C-terminal hydrolase l1 in tumorigenesis.
Hurst-Kennedy J; Chin LS; Li L
Biochem Res Int; 2012; 2012():123706. PubMed ID: 22811913
[TBL] [Abstract][Full Text] [Related]
19. [Research advances on ubiquitin C-terminal hydrolase in oncogenesis and progression].
Yu J; Chen WL
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 44(2):217-22. PubMed ID: 26038143
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of catalytic cysteine of human deubiquitinase BAP1 triggers misfolding and aggregation in addition to functional loss.
Puri S; Hsu SD
Biochem Biophys Res Commun; 2022 Apr; 599():57-62. PubMed ID: 35176625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
